Eli Lilly and Company announced that Leena Gandhi, M.D., Ph.D., a prestigious thoracic oncologist with a focus on immunotherapy and early drug development, will join Lilly Oncology on June 25, 2018 to lead immuno-oncology medical development.
April 30, 2018
· 2 min read